Literature DB >> 19779694

Cognitive decline associated with dementia and type 2 diabetes: the interplay of risk factors.

C Messier1, M Gagnon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19779694     DOI： 10.1007/s00125-009-1533-2

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  22 in total

Review 1.  Why is learning and memory dysfunction in Type 2 diabetes limited to older adults?

Authors:  C M Ryan; M Geckle
Journal:  Diabetes Metab Res Rev       Date:  2000 Sep-Oct       Impact factor: 4.876

2.  APOE genotype and cognitive decline in a middle-aged cohort.

Authors:  C K Blair; A R Folsom; D S Knopman; M S Bray; T H Mosley; E Boerwinkle
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

3.  Improving metabolic control leads to better working memory in adults with type 2 diabetes.

Authors:  Christopher M Ryan; Martin I Freed; Julie A Rood; Alexander R Cobitz; Brian R Waterhouse; Mark W J Strachan
Journal:  Diabetes Care       Date:  2006-02       Impact factor: 19.112

4.  Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study.

Authors:  J Heitner; D Dickson
Journal:  Neurology       Date:  1997-11       Impact factor: 9.910

5.  Apolipoprotein-E genotyping of diabetic dementia patients: is diabetes rare in Alzheimer's disease?

Authors:  K A Nielson; J H Nolan; N C Berchtold; C A Sandman; R A Mulnard; C W Cotman
Journal:  J Am Geriatr Soc       Date:  1996-08       Impact factor: 5.562

6.  Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging.

Authors:  Chris MacKnight; Kenneth Rockwood; Erin Awalt; Ian McDowell
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

7.  Cognitive dysfunction and its clinical and radiological determinants in patients with symptomatic arterial disease and diabetes.

Authors:  A M Tiehuis; W P Th M Mali; A F van Raamt; F L J Visseren; G J Biessels; M J E van Zandvoort; L J Kappelle; Y van der Graaf
Journal:  J Neurol Sci       Date:  2009-03-06       Impact factor: 3.181

8.  Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study.

Authors:  Fumiko Irie; Annette L Fitzpatrick; Oscar L Lopez; Lewis H Kuller; Rita Peila; Anne B Newman; Lenore J Launer
Journal:  Arch Neurol       Date:  2008-01

Review 9.  Diabetes, Alzheimer's disease and apolipoprotein genotype.

Authors:  Claude Messier
Journal:  Exp Gerontol       Date:  2003-09       Impact factor: 4.032

Review 10.  Insulin and neurodegenerative disease: shared and specific mechanisms.

Authors:  Suzanne Craft; G Stennis Watson
Journal:  Lancet Neurol       Date:  2004-03       Impact factor: 44.182
View more
  9 in total

1.  Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer's disease.

Authors:  Laura D Baker; Laura L Frank; Karen Foster-Schubert; Pattie S Green; Charles W Wilkinson; Anne McTiernan; Brenna A Cholerton; Stephen R Plymate; Mark A Fishel; G Stennis Watson; Glen E Duncan; Pankaj D Mehta; Suzanne Craft
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer's disease.

Authors:  James L Searcy; Jeremiah T Phelps; Tristano Pancani; Inga Kadish; Jelena Popovic; Katie L Anderson; Tina L Beckett; Michael P Murphy; Kuey-Chu Chen; Eric M Blalock; Philip W Landfield; Nada M Porter; Olivier Thibault
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  Kinetics and Molecular Docking Study of an Anti-diabetic Drug Glimepiride as Acetylcholinesterase Inhibitor: Implication for Alzheimer's Disease-Diabetes Dual Therapy.

Authors:  Syed Mohd Danish Rizvi; Sibhghatulla Shaikh; Deeba Naaz; Shazi Shakil; Adnan Ahmad; Mohd Haneef; Adel M Abuzenadah
Journal:  Neurochem Res       Date:  2016-02-17       Impact factor: 3.996

4.  Comorbid depression is associated with an increased risk of dementia diagnosis in patients with diabetes: a prospective cohort study.

Authors:  Wayne J Katon; Elizabeth H B Lin; Lisa H Williams; Paul Ciechanowski; Susan R Heckbert; Evette Ludman; Carolyn Rutter; Paul K Crane; Malia Oliver; Michael Von Korff
Journal:  J Gen Intern Med       Date:  2010-01-28       Impact factor: 5.128

5.  Genetic polymorphisms of nerve growth factor receptor (NGFR) and the risk of Alzheimer's disease.

Authors:  Hui-Chi Cheng; Yu Sun; Liang-Chuan Lai; Shih-Yuan Chen; Wen-Chung Lee; Jen-Hau Chen; Ta-Fu Chen; Hua-Hsiang Chen; Li-Li Wen; Ping-Keung Yip; Yi-Min Chu; Wei J Chen; Yen-Ching Chen
Journal:  J Negat Results Biomed       Date:  2012-01-12

6.  Rosiglitazone and cognitive stability in older individuals with type 2 diabetes and mild cognitive impairment.

Authors:  Angela M Abbatecola; Fabrizia Lattanzio; Anna M Molinari; Michele Cioffi; Luigi Mansi; Pierfrancesco Rambaldi; Luigi DiCioccio; Federico Cacciapuoti; Raffaele Canonico; Giuseppe Paolisso
Journal:  Diabetes Care       Date:  2010-04-30       Impact factor: 19.112

7.  Protein modification by dicarbonyl molecular species in neurodegenerative diseases.

Authors:  Wesley M Williams; Aaron Weinberg; Mark A Smith
Journal:  J Amino Acids       Date:  2011-03-14

Review 8.  Role of anti-diabetic drugs as therapeutic agents in Alzheimer's disease.

Authors:  Syed Mohd Danish Rizvi; Sibhghatulla Shaikh; Shah Mohammad Abbas Waseem; Shazi Shakil; Adel M Abuzenadah; Deboshree Biswas; Shams Tabrez; Ghulam Md Ashraf; Mohammad Amjad Kamal
Journal:  EXCLI J       Date:  2015-05-19       Impact factor: 4.068

9.  Open- and Closed-Skill Exercise Interventions Produce Different Neurocognitive Effects on Executive Functions in the Elderly: A 6-Month Randomized, Controlled Trial.

Authors:  Chia-Liang Tsai; Chien-Yu Pan; Fu-Chen Chen; Yu-Ting Tseng
Journal:  Front Aging Neurosci       Date:  2017-09-12       Impact factor: 5.750
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.